ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Efficacy of TRT in Correcting Anemia in Men With Hypogonadism
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 268326" data-attributes="member: 13851"><p><strong>Figure 1. Study Flow Diagram</strong></p><p>[ATTACH=full]38605[/ATTACH]</p><p>All randomized participants who could be classified as having anemia or not having anemia at baseline and met the eligibility criteria for the parent trial, as well as the anemia study, were included in the analysis. As this was an event-driven trial and the trial design required the participants to be followed up until the accrual of 256 adjudicated major adverse cardiovascular events. Participants were considered in the study if their last visit date in the trial database fell within or after the defined visit window. All randomized participants were included in the primary and secondary analyses if they had at least 1 postbaseline hemoglobin value.</p></blockquote><p></p>
[QUOTE="madman, post: 268326, member: 13851"] [B]Figure 1. Study Flow Diagram[/B] [ATTACH type="full"]38605[/ATTACH] All randomized participants who could be classified as having anemia or not having anemia at baseline and met the eligibility criteria for the parent trial, as well as the anemia study, were included in the analysis. As this was an event-driven trial and the trial design required the participants to be followed up until the accrual of 256 adjudicated major adverse cardiovascular events. Participants were considered in the study if their last visit date in the trial database fell within or after the defined visit window. All randomized participants were included in the primary and secondary analyses if they had at least 1 postbaseline hemoglobin value. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Efficacy of TRT in Correcting Anemia in Men With Hypogonadism
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top